[HTML] springer.comFull View

[HTML][HTML] RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signatures

EM Packeiser, L Taher, W Kong, M Ernst, J Beck… - Cancer cell …, 2022 - Springer
Background Canine prostate adenocarcinoma (PAC) and transitional cell carcinoma (TCC)
are typically characterized by metastasis and chemoresistance. Cell lines are important …
被引用次数：4 相关文章
[HTML] nih.gov

[HTML][HTML] RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signatures

EM Packeiser, L Taher, W Kong, M Ernst… - Cancer Cell …, 2022 - ncbi.nlm.nih.gov
Background Canine prostate adenocarcinoma (PAC) and transitional cell carcinoma (TCC)
are typically characterized by metastasis and chemoresistance. Cell lines are important …
[PDF] tiho-hannover.de

[PDF][PDF] RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signatures

EM Packeiser, L Taher, W Kong, M Ernst, J Beck… - 2022 - elib.tiho-hannover.de
Background: Canine prostate adenocarcinoma (PAC) and transitional cell carcinoma (TCC)
are typically characterized by metastasis and chemoresistance. Cell lines are important …

RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signatures.

EM Packeiser, L Taher, W Kong, M Ernst… - Cancer Cell …, 2022 - europepmc.org
Background Canine prostate adenocarcinoma (PAC) and transitional cell carcinoma (TCC)
are typically characterized by metastasis and chemoresistance. Cell lines are important …

RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signatures.

EM Packeiser, L Taher, W Kong… - Cancer Cell …, 2022 - search.ebscohost.com
Background: Canine prostate adenocarcinoma (PAC) and transitional cell carcinoma (TCC)
are typically characterized by metastasis and chemoresistance. Cell lines are important …

RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signatures

EM Packeiser, L Taher, W Kong… - Cancer cell …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Canine prostate adenocarcinoma (PAC) and transitional cell carcinoma (TCC)
are typically characterized by metastasis and chemoresistance. Cell lines are important …
[HTML] biomedcentral.com

[HTML][HTML] RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signatures

EM Packeiser, L Taher, W Kong… - Cancer Cell …, 2022 - cancerci.biomedcentral.com
Canine prostate adenocarcinoma (PAC) and transitional cell carcinoma (TCC) are typically
characterized by metastasis and chemoresistance. Cell lines are important model systems …

RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signatures

EM Packeiser, L Taher, W Kong… - Cancer Cell …, 2022 - graz.elsevierpure.com
BACKGROUND: Canine prostate adenocarcinoma (PAC) and transitional cell carcinoma
(TCC) are typically characterized by metastasis and chemoresistance. Cell lines are …

RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signatures

EM Packeiser, L Taher, W Kong, M Ernst… - Cancer Cell …, 2022 - search.proquest.com
Background Canine prostate adenocarcinoma (PAC) and transitional cell carcinoma (TCC)
are typically characterized by metastasis and chemoresistance. Cell lines are important …

RNA-seq of nine canine prostate cancer cell lines reveals diverse therapeutic target signatures.

EM Packeiser, L Taher, W Kong, M Ernst… - Cancer Cell …, 2022 - go.gale.com
Background Canine prostate adenocarcinoma (PAC) and transitional cell carcinoma (TCC)
are typically characterized by metastasis and chemoresistance. Cell lines are important …